BACE Fluorescent Probes for Real-Time Enzyme Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Developing potent and specific beta-secretase (BACE) inhibitors has been challenging due to the enzyme's broad substrate specificity and large active site, with existing assays being slow, expensive, and laborious, and many inhibitors fail to inhibit BACE activity in cellular models because they do not access the endosomal compartments where BACE is active.
Innovation Solution
The development of BACE fluorescent molecular probes that comprise a fluorescent group, a BACE substrate module, a quenching group, a linker molecule, and a cell membrane anchor, allowing for real-time imaging of BACE activity in living cells and organisms without the need for genetic manipulation or antibodies, and enabling the assessment of potential inhibitors' efficacy by detecting changes in fluorescence signals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing FRET-based fluorescence assays are used to monitor BACE activity, then inhibitor efficacy can be assessed in vitro, but the assays are slow, expensive, and laborious
Solution Approach 1:
The patent employs fluorescent probes that undergo color/fluorescence changes upon BACE cleavage. The probes contain a fluorophore that is quenched in the intact probe but becomes fluorescent when cleaved by BACE, enabling rapid real-time monitoring of BACE activity and inhibitor efficacy without lengthy assay procedures
Solution Approach 2:
The patent replaces complex mechanical and procedural assay steps with a simple fluorescence detection system. Instead of multiple manual operations and lengthy processing steps, the assay relies on optical detection of fluorescence signals, dramatically reducing assay time and labor requirements
2Ease of operation
If conventional FRET assays are used, then inhibitor screening can be performed, but the assays require genetic manipulation and cannot easily detect real-time fluorescence changes
Solution Approach 1:
The patent extracts the fluorescent detection capability from complex genetic manipulation systems. By using cell-permeable fluorescent probes that directly interact with BACE, the assay eliminates the need for genetic manipulation of cell lines while maintaining the ability to detect real-time BACE activity and inhibitor effects
Solution Approach 2:
The patent introduces fluorescent probe molecules as intermediaries that bridge the gap between BACE activity and detection. These probes penetrate cell membranes and directly report BACE cleavage events through fluorescence changes, serving as simple mediators that eliminate complex genetic systems
3Reliability
If inhibitors are designed based on in vitro assays, then apparent inhibitor efficacy is achieved, but the inhibitors fail to inhibit BACE activity in cellular models due to inability to access endosomal compartments
Solution Approach 1:
The patent changes the physical-chemical parameters of the fluorescent probes to enable cell membrane permeability. By optimizing probe properties such as lipophilicity and molecular size, the probes can penetrate cell membranes and reach endosomal compartments where BACE is active, allowing accurate assessment of inhibitor efficacy in cellular models
Solution Approach 2:
The fluorescent probes serve as intermediaries that can access endosomal compartments and report BACE activity in situ. This allows inhibitors to be evaluated in their actual cellular context, providing reliable data on whether they can reach and inhibit BACE in the correct subcellular location
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These probes enable rapid, non-toxic, and effective imaging of BACE activity in living cells and organisms, allowing for the evaluation of potential inhibitors' ability to access and inhibit BACE in its active location, thereby overcoming the limitations of existing assays and improving the identification of effective BACE inhibitors.
Implementation Method 1
A is a fluorescent group
Implementation Method 2
A popular assay used to monitor inhibitor efficacy in vitro utilizes a FRET substrate that increases its fluorescence emission when hydrolyzed by BACE
Data Source
AI summary
Molecular probes are provided for use in fluorescence microscopy procedures for monitoring beta-secretase enzyme (BACE) activity in living cells and organisms. The probes may be useful for monitoring Alzheimer's Disease-associated BACE in living cells. By fluorescing when hydrolyzed by BACE, the probes can allow for real-time spatial and temporal assessment of enzymatic activity without the need for mutated cell lines or antibodies. The molecular probes may also be used to screen libraries of potential BACE inhibitors or evaluate how external stimuli affect BACE activity.